Two top Indian drug firms Ranbaxy and Cipla have bid for the generic drugs business of German pharmaceutical giant Merck KGaA, but Dr Reddy's Laboratories has pulled out, the companies said Tuesday.
India's Ranbaxy Cipla bid for Merck's generic drugs business.